Immune responses and clinical outcomes in STAND, a randomized phase 2 study evaluating optimal sequencing of sipuleucel-T (sip-T) and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC) after local therapy failure

The requested reference [d6c92e029ceebed1e0edf83205562f3a10e3d056] no longer exists in our database. It has been replaced by the current reference: [400eac5c139c64b9acdf26c3aae47f2728a97be6]

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2015
This article has no abstract
Epistemonikos ID: 43ad18d1b4dcf63211a682a4b84c37193db45429
First added on: Feb 07, 2025